Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p281
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 281/312)
Character Range: 17240079–17248800

(i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C16099              P16099         CN16099          Itraconazole                                                           Disseminated pulmonary histoplasmosis infection                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Compliance with Authority Required procedures - Streamlined Authority Code 16099
                                                                                                                           Treatment and maintenance therapy
                                                                                                                           Patient must be diagnosed with acquired immunodeficiency syndrome (AIDS); AND
                                                                                                                           Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C16101              P16101         CN16101          Itraconazole                                                           Chronic pulmonary histoplasmosis infection                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures - Streamlined Authority Code 16101
                                                                                                                           Treatment and maintenance therapy
                                                                                                                           Patient must be diagnosed with acquired immunodeficiency syndrome (AIDS); AND
                                                                                                                           Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C16102              P16102         CN16102          Itraconazole                                                           Oesophageal candidiasis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Compliance with Authority Required procedures - Streamlined Authority Code 16102
                                                                                                                           Patient must be immunosuppressed; AND
                                                                                                                           Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C16104              P16104         CN16104          Fremanezumab                                                           Treatment-resistant migraine                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Compliance with Authority Required procedures - Streamlined Authority Code 16104
                                                                                                                           Initial treatment
                                                                                                                           Must be treated by a neurologist; or
                                                                                                                           Must be treated by a general practitioner in consultation with a neurologist; AND
                                                                                                                           Patient must not be undergoing concurrent treatment with the following PBS benefits: (i) botulinum toxin type A listed for this PBS indication, (ii) another drug in the same pharmacological class as this drug listed for this PBS indication; AND
                                                                                                                           Patient must have experienced at least 8 migraine headache days per month, over a period of at least 6 months, prior to commencement of treatment with this medicine for this condition; AND
                                                                                                                           Patient must have experienced an inadequate response, intolerance or a contraindication to at least three prophylactic migraine medications prior to commencement of treatment with this drug for this condition; AND
                                                                                                                           Patient must be appropriately managed by their practitioner for medication overuse headache, prior to initiation of treatment with this drug;
                                                                                                                           Patient must be at least